Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:VYX - US62886E1082 - Common Stock

10.67 USD
-0.15 (-1.39%)
Last: 1/16/2026, 8:04:00 PM
10.67 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

3

Overall VYX gets a fundamental rating of 3 out of 10. We evaluated VYX against 277 industry peers in the Software industry. VYX may be in some trouble as it scores bad on both profitability and health. VYX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year VYX was profitable.
  • VYX had a negative operating cash flow in the past year.
  • In multiple years VYX reported negative net income over the last 5 years.
  • Of the past 5 years VYX 4 years had a positive operating cash flow.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

  • VYX has a Return On Assets (-1.52%) which is comparable to the rest of the industry.
  • VYX has a Return On Equity (-5.43%) which is in line with its industry peers.
  • VYX's Return On Invested Capital of 3.31% is fine compared to the rest of the industry. VYX outperforms 70.04% of its industry peers.
Industry RankSector Rank
ROA -1.52%
ROE -5.43%
ROIC 3.31%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • In the last couple of years the Profit Margin of VYX has grown nicely.
  • VYX has a better Operating Margin (4.57%) than 67.15% of its industry peers.
  • VYX's Operating Margin has declined in the last couple of years.
  • The Gross Margin of VYX (22.76%) is worse than 81.23% of its industry peers.
  • In the last couple of years the Gross Margin of VYX has declined.
Industry RankSector Rank
OM 4.57%
PM (TTM) N/A
GM 22.76%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VYX is destroying value.
  • VYX has less shares outstanding than it did 1 year ago.
  • VYX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for VYX has been reduced compared to a year ago.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • VYX has an Altman-Z score of 1.28. This is a bad value and indicates that VYX is not financially healthy and even has some risk of bankruptcy.
  • VYX has a Altman-Z score (1.28) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.98 indicates that VYX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of VYX (0.98) is worse than 75.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.32
WACC10.47%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that VYX should not have too much problems paying its short term obligations.
  • The Current ratio of VYX (1.13) is worse than 69.31% of its industry peers.
  • A Quick Ratio of 0.94 indicates that VYX may have some problems paying its short term obligations.
  • VYX has a worse Quick ratio (0.94) than 77.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.94
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

  • VYX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 235.00%, which is quite impressive.
  • VYX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.03% yearly.
  • VYX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -61.25%.
  • Measured over the past years, VYX shows a very negative growth in Revenue. The Revenue has been decreasing by -16.39% on average per year.
EPS 1Y (TTM)235%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-101.95%
Revenue 1Y (TTM)-61.25%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-3.8%

3.2 Future

  • Based on estimates for the next years, VYX will show a very strong growth in Earnings Per Share. The EPS will grow by 27.36% on average per year.
  • Based on estimates for the next years, VYX will show a decrease in Revenue. The Revenue will decrease by -8.78% on average per year.
EPS Next Y101.34%
EPS Next 2Y53.66%
EPS Next 3Y27.36%
EPS Next 5YN/A
Revenue Next Year-7.17%
Revenue Next 2Y-11.81%
Revenue Next 3Y-8.78%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.17, the valuation of VYX can be described as correct.
  • Based on the Price/Earnings ratio, VYX is valued cheaply inside the industry as 84.48% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of VYX to the average of the S&P500 Index (27.38), we can say VYX is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.27 indicates a reasonable valuation of VYX.
  • Based on the Price/Forward Earnings ratio, VYX is valued cheaper than 87.00% of the companies in the same industry.
  • VYX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
Industry RankSector Rank
PE 13.17
Fwd PE 10.27
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VYX is valued cheaper than 93.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.48
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as VYX's earnings are expected to grow with 27.36% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y53.66%
EPS Next 3Y27.36%

0

5. Dividend

5.1 Amount

  • No dividends for VYX!.
Industry RankSector Rank
Dividend Yield 0%

NCR VOYIX CORP

NYSE:VYX (1/16/2026, 8:04:00 PM)

After market: 10.67 0 (0%)

10.67

-0.15 (-1.39%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners114.29%
Inst Owner ChangeN/A
Ins Owners0.43%
Ins Owner Change-3.03%
Market Cap1.48B
Revenue(TTM)2.65B
Net Income(TTM)-61.00M
Analysts85
Price Target15.81 (48.17%)
Short Float %17.51%
Short Ratio11.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP-22.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.58%
Min EPS beat(2)38.46%
Max EPS beat(2)44.71%
EPS beat(4)4
Avg EPS beat(4)94.55%
Min EPS beat(4)38.46%
Max EPS beat(4)239.46%
EPS beat(8)6
Avg EPS beat(8)41.31%
EPS beat(12)8
Avg EPS beat(12)31.35%
EPS beat(16)11
Avg EPS beat(16)21.93%
Revenue beat(2)2
Avg Revenue beat(2)1.38%
Min Revenue beat(2)1.11%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.51%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)1.66%
Revenue beat(8)4
Avg Revenue beat(8)-2.13%
Revenue beat(12)6
Avg Revenue beat(12)7.55%
Revenue beat(16)7
Avg Revenue beat(16)5.03%
PT rev (1m)-3.12%
PT rev (3m)-2.36%
EPS NQ rev (1m)1.51%
EPS NQ rev (3m)4.12%
EPS NY rev (1m)0%
EPS NY rev (3m)11.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 13.17
Fwd PE 10.27
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB N/A
EV/EBITDA 6.48
EPS(TTM)0.81
EY7.59%
EPS(NY)1.04
Fwd EY9.74%
FCF(TTM)-4.34
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS19.13
BVpS8.12
TBVpS-3.51
PEG (NY)0.13
PEG (5Y)N/A
Graham Number12.16
Profitability
Industry RankSector Rank
ROA -1.52%
ROE -5.43%
ROCE 4.19%
ROIC 3.31%
ROICexc 3.67%
ROICexgc 9.58%
OM 4.57%
PM (TTM) N/A
GM 22.76%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-36.27%
ROICexgc growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score1
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 3.1
Cap/Depr 69.1%
Cap/Sales 6.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.94
Altman-Z 1.28
F-Score1
WACC10.47%
ROIC/WACC0.32
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)235%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-101.95%
EPS Next Y101.34%
EPS Next 2Y53.66%
EPS Next 3Y27.36%
EPS Next 5YN/A
Revenue 1Y (TTM)-61.25%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-3.8%
Revenue Next Year-7.17%
Revenue Next 2Y-11.81%
Revenue Next 3Y-8.78%
Revenue Next 5YN/A
EBIT growth 1Y-27.11%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year373.52%
EBIT Next 3Y79.51%
EBIT Next 5Y46.94%
FCF growth 1Y-216.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-148.35%
OCF growth 3YN/A
OCF growth 5YN/A

NCR VOYIX CORP / VYX FAQ

Can you provide the ChartMill fundamental rating for NCR VOYIX CORP?

ChartMill assigns a fundamental rating of 3 / 10 to VYX.


What is the valuation status for VYX stock?

ChartMill assigns a valuation rating of 6 / 10 to NCR VOYIX CORP (VYX). This can be considered as Fairly Valued.


Can you provide the profitability details for NCR VOYIX CORP?

NCR VOYIX CORP (VYX) has a profitability rating of 3 / 10.


What is the valuation of NCR VOYIX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NCR VOYIX CORP (VYX) is 13.17 and the Price/Book (PB) ratio is 1.31.


What is the financial health of NCR VOYIX CORP (VYX) stock?

The financial health rating of NCR VOYIX CORP (VYX) is 2 / 10.